Background/Aims Transforming growth factor-β1 (TGF-β1) induction of epithelial-mesenchymal transition (EMT) is one of the mechanisms by which colorectal cancer (CRC) cells acquire migratory and invasive capacities, and subsequently metastasize. Parthenolide (PT) expresses multiple anti-cancer and anti-inflammatory activities that inhibit nuclear factor κB by targeting the IκB kinase complex. In the present study, we aimed to investigate whether PT can inhibit TGF-β1-induced EMT in CRC cell lines.
Methods HT-29 and SW480 cell lines were used in the experiment. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and sub-G1 analysis was measured by flow cytometry. The induction of EMT by TGF-β1 and inhibition of the process by PT was analyzed by phase contrast microscopy, wounding healing, cellular migration and invasion assays, and Western blotting.
Results TGF-β1 inhibits HT-29 cell proliferation, but has no effect on SW480 cell proliferation; different concentrations of TGF-β1 did not induce apoptosis in HT-29 and SW480 cells. PT attenuates TGF-β1-induced elongated, fibroblast-like shape changing in cells. PT inhibits TGF-β1-induced cell migration and cell invasion. In addition, other EMT markers such as β-catenin, Vimentin, Snail, and Slug were suppressed by PT, while E-cadherin was increased by PT.
Conclusions Our findings show that PT inhibits TGF-β1-induced EMT by suppressing the expression of the mesenchymal protein and increasing expression of the epithelial protein. These findings suggest a novel approach for CRC treatment by suppression of TGF-β1-induced EMT.
Citations
Citations to this article as recorded by
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko Biomedicines.2025; 13(1): 133. CrossRef
Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide Jian Li, Xin Li, Hongwei Liu Frontiers in Pharmacology.2025;[Epub] CrossRef
Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi Biomolecules.2025; 15(2): 268. CrossRef
Cumin (Cuminum cyminum L.) seeds accelerates wound healing in rats: Possible molecular mechanisms Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Yaseen Galali, Ayman M. Al‐Qaaneh, Gökhan Akçakavak, Nur Ain Salehen, Rawaz Rizgar Hassan, Ramzi A. Mothana, Mahmood Ameen Abdulla, Omer I. Fantoukh, Sidig Hasson, Mohammed F. Hawwal Skin Research and Technology.2024;[Epub] CrossRef
TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance Allan M. Johansen, Steven D. Forsythe, Callum T. McGrath, Grayson Barker, Hugo Jimenez, Ravi K. Paluri, Boris C. Pasche Clinical Cancer Research.2024; 30(17): 3676. CrossRef
NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, Sina Sadati, Arash Raisi, AmirMohammad Abolhassani, Reza Eshraghi, Mahmood Khaksary Mahabady, Neda Rahimian, Hamed Mirzaei European Journal of Medical Research.2024;[Epub] CrossRef
Bitter taste signaling in cancer Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos Life Sciences.2023; 315: 121363. CrossRef
Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz Cell Biology International.2023; 47(9): 1638. CrossRef
Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany Life Sciences.2023; 331: 122037. CrossRef
TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer Sumeet Singh, Vinita Gouri, Mukesh Samant Medical Oncology.2023;[Epub] CrossRef
The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy Tao An, Huanhuan Yin, Yanting Lu, Feng Liu Drug Design, Development and Therapy.2022; Volume 16: 1255. CrossRef
Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman Life Sciences.2022; 301: 120610. CrossRef
Cinnamomum bejolghota Extract Inhibits Colorectal Cancer Cell Metastasis and TGF-β1-Induced Epithelial-Mesenchymal Transition via Smad and Non-Smad Signaling Pathway Athicha Kittiwattanokhun, Sukanda Innajak, Etsu Tashiro, Masaya Imoto, Ramida Watanapokasin Scientia Pharmaceutica.2022; 90(2): 30. CrossRef
Autoimmunity and Cancer—Two Sides of the Same Coin Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska, Piotr Trzonkowski Frontiers in Immunology.2022;[Epub] CrossRef
Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
Plants as a Source of Anticancer Agents: From Bench to Bedside Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, Reem Ali Hamed, Dima Awajan, Sara Feras Abuarab, Lena Hisham Odeh, Samar Khater, Lina T. Al Kury Molecules.2022; 27(15): 4818. CrossRef
Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer Nima Zafari, Mahla Velayati, Mohammadreza Nassiri, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan Current Pharmaceutical Design.2022; 28(28): 2298. CrossRef
The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities Rubén Varela‐Calviño, Marta Rodríguez‐Quiroga, Patrícia Dias Carvalho, Flavia Martins, André Serra‐Roma, Lorena Vázquez‐Iglesias, María Páez de la Cadena, Sérgia Velho, Oscar J. Cordero IUBMB Life.2021; 73(5): 761. CrossRef
Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
Bo Tian, Yuhang Xiao, Junliang Ma, Wei Ou, Hui Wang, Jie Wu, Jinming Tang, Baihua Zhang, Xiaojuan Liao, Desong Yang, Zhining Wu, Xu Li, Yong Zhou, Min Su, Wenxiang Wang OncoTargets and Therapy.2020; Volume 13: 7447. CrossRef
Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity Alex S. Quy, Xingjian Li, Louise Male, Tatjana Stankovic, Angelo Agathanggelou, John S. Fossey Tetrahedron.2020; : 131631. CrossRef
Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids Chang Hoon Lee Cancers.2019; 11(12): 1841. CrossRef